OBJECTIVE: We developed a personalized intervention for depressed patients with COPD (PID-C) aimed to mobilize patients to participate in the care of both conditions. We showed that PID-C reduced depressive symptoms and dyspnea-related disability more than usual care over 28 weeks. This study focused on untangling key therapeutic ingredients of PID-C. DESIGN: Randomized controlled trial. SETTING: Community. PARTICIPANTS: 138 patients who received the diagnoses of COPD and major depression after screening 898 consecutive admissions for acute inpatient pulmonary rehabilitation. INTERVENTION: Nine sessions of PID-C compared with usual care over 28 weeks. MEASUREMENTS: Primary outcome measures were the 17-item Hamilton Depression Rating Scale and the Pulmonary Functional Status and Dyspnea Questionnaire-Modified. Other measures were adherence to rehabilitation exercise (≥2 hours per week) and adherence to adequate antidepressant prescriptions. RESULTS: Low severity of dyspnea-related disability and adherence to antidepressants predicted subsequent improvement of depression. Exercise and low depression severity predicted improvement of dyspnea-related disability. CONCLUSIONS: PID-C led to an interacting spiral of improvement in both depression and disability in a gravely medically ill population with a 17% mortality rate over 28 weeks and an expected deterioration in disability. The interrelationship of the course of depression and dyspnea-related disability underscores the need to target adherence to both antidepressants and chronic obstructive pulmonary disease rehabilitation. PID-C may serve as a care management model for depressed persons suffering from medical illnesses with a deteriorating course.
RCT Entities:
OBJECTIVE: We developed a personalized intervention for depressedpatients with COPD (PID-C) aimed to mobilize patients to participate in the care of both conditions. We showed that PID-C reduced depressive symptoms and dyspnea-related disability more than usual care over 28 weeks. This study focused on untangling key therapeutic ingredients of PID-C. DESIGN: Randomized controlled trial. SETTING: Community. PARTICIPANTS: 138 patients who received the diagnoses of COPD and major depression after screening 898 consecutive admissions for acute inpatient pulmonary rehabilitation. INTERVENTION: Nine sessions of PID-C compared with usual care over 28 weeks. MEASUREMENTS: Primary outcome measures were the 17-item Hamilton Depression Rating Scale and the Pulmonary Functional Status and Dyspnea Questionnaire-Modified. Other measures were adherence to rehabilitation exercise (≥2 hours per week) and adherence to adequate antidepressant prescriptions. RESULTS: Low severity of dyspnea-related disability and adherence to antidepressants predicted subsequent improvement of depression. Exercise and low depression severity predicted improvement of dyspnea-related disability. CONCLUSIONS:PID-C led to an interacting spiral of improvement in both depression and disability in a gravely medically ill population with a 17% mortality rate over 28 weeks and an expected deterioration in disability. The interrelationship of the course of depression and dyspnea-related disability underscores the need to target adherence to both antidepressants and chronic obstructive pulmonary disease rehabilitation. PID-C may serve as a care management model for depressedpersons suffering from medical illnesses with a deteriorating course.
Authors: Daisy J A Janssen; Martijn A Spruit; Carsten Leue; Candy Gijsen; Henry Hameleers; Jos M G A Schols; Emiel F M Wouters Journal: Chron Respir Dis Date: 2010-08 Impact factor: 2.444
Authors: Mark E Kunik; Kent Roundy; Connie Veazey; Julianne Souchek; Peter Richardson; Nelda P Wray; Melinda A Stanley Journal: Chest Date: 2005-04 Impact factor: 9.410
Authors: Patricia P Katz; Steven Gregorich; Mark Eisner; Laura Julian; Hubert Chen; Edward Yelin; Paul D Blanc Journal: J Cardiopulm Rehabil Prev Date: 2010 Mar-Apr Impact factor: 2.081
Authors: Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania Journal: Chest Date: 2008-10 Impact factor: 9.410
Authors: George S Alexopoulos; Dimitris N Kiosses; Jo Anne Sirey; Dora Kanellopoulos; Joanna K Seirup; Richard S Novitch; Samiran Ghosh; Samprit Banerjee; Patrick J Raue Journal: Am J Geriatr Psychiatry Date: 2013-08-14 Impact factor: 4.105
Authors: George S Alexopoulos; Jo Anne Sirey; Samprit Banerjee; Dimitris N Kiosses; Cristina Pollari; Richard S Novitch; Amanda Artis; Patrick J Raue Journal: Am J Geriatr Psychiatry Date: 2016-07-20 Impact factor: 4.105
Authors: Abebaw Mengistu Yohannes; Patrick J Raue; Dora Kanellopoulos; Amanda McGovern; Jo Anne Sirey; Dimitris N Kiosses; Samprit Banerjee; Joanna K Seirup; Richard S Novitch; George S Alexopoulos Journal: Chest Date: 2016-01-12 Impact factor: 9.410
Authors: Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield Journal: Ann Am Thorac Soc Date: 2016-02